Technology Access Framework News Today

Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Spear Bio, Inc.announced that the Institute’s DNA...

The technology fills a present gap in diagnostic testing and could contribute to extending the four walls of the health system for COVID-19 and beyond...

Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Spear Bio, Inc.announced that the Institute's DNA nanotechnology-driven ultrasensitive SPEAR protein-detection technology has been licensed to the newly formed Boston-based startup.

Wyss Institute at Harvard University, Aug. 23, 2022 (GLOBE NEWSWIRE) -- (BOSTON) — Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Spear Bio, Inc. announced that

The technology fills a present gap in diagnostic testing and could contribute to extending the four walls of the health system for COVID-19 and beyond...

Affordable rapid multiplexed biomarker detection at the point-of-care for patients and practitioners...

The low-cost multiplexed electrochemical biomarker detection platform will be commercialized in point-of-care diagnostics to be put into the hands of...

Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Australian biotech company The iQ Group Global Ltd. announced that the Institute's electrochemical eRapid technology has been licensed to Antisoma Therapeutics Pty. Ltd., a subsidiary of The iQ Group Global.

IQX Limited (NSX:IQX) today announced it has received a worldwide license from Harvards Office of Technology Development to commercialise diagnostic technology developed at the Wyss Institute for Biologically Inspired Engineering at Harvard University.

Wyss Institute for Biologically Inspired Engineering at Harvard University, March 07, 2022 (GLOBE NEWSWIRE) -- (BOSTON) — Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Australian